Pediatric oncohematologist senior
Hospital General Universitario Gregorio Marañón, Spain
I completed my degree in 1996, and specialty in Pediatrics in 2001, with especial dedication
to pediatric oncology. I got my Ph D in 2003 - cum laude.
I worked as a Pediatric Oncohaematologist and
as a pediatric emergency senior doctor. From january 200
6 I have been working in Pediatric
and Adolescent Hematology and Oncology Unit at Gregorio Marañón University Hospital,
especially focused on sarcomas. I am PI and Spanish pediatric coordinator for rEECur trial
(FPP 7 grant) -for recurrent and refractory Ewing sarcoma patients-, and I will also be the
Spanish pediatric coordinator for INTER-EWING 1 . I am PI and SI of multiple pediatric
oncohematology trials. Active member of the
following national and international cooperative groups: SEHOP -Pediatric hematooncology
Spanish Society- (working subgroups of bone tumors, soft tissue tumors and secondary
effects); GEIS (Spanish Sarcomas Research Group) coordinating different GEIS working
subgroups: Ewing sarcoma, Rhabdomyosarcoma and AYA subgroups. In 2021 I have became
a member of the GEIS managing board. In the last years I have become the spanish pediatric
oncohematologist reference person on the EUROEWING Consortium, the recently created
FOSTER (European Osteosarcoma Consortium) and of PANCARE (Pan-european network
for care of survivors after Childhood and Adolescent Cancer). As a paediatrician I am an active
member of AEP (Asociación española Pediatría). My teaching current activity includes
being Associate Proffesor at Complutense University in Madrid and professor in the Master of
Musculoskeletal tumors in European University-MAdrid. At Gregorio Marañón University
Hospital, I am actively involved in different groups: Sarcomas group (as we are a national
reference center recently recognised by ERN Euracan network), Heredofamilial Cancer Group,
Vascular Malformations Group, Tissue and Tumor Commitee Group. This is my current activity,
but in the future I would like to involve in treating children with cancer in developing countries.